Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$15.36 - $27.51 $622,080 - $1.11 Million
40,500 New
40,500 $1 Million
Q3 2020

Nov 12, 2020

SELL
$46.35 - $61.69 $449,595 - $598,393
-9,700 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$38.58 - $65.07 $6.4 Million - $10.8 Million
-165,900 Reduced 94.48%
9,700 $558,000
Q1 2020

May 13, 2020

BUY
$32.73 - $50.78 $5.75 Million - $8.92 Million
175,600 New
175,600 $7.06 Million

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.